A carregar...
Promise and challenges on the horizon of MET-targeted cancer therapeutics
MET (MNNG HOS transforming gene) is one of the receptor tyrosine kinases whose activities are frequently altered in human cancers, and it is a promising therapeutic target. MET is normally activated by its lone ligand, hepatocyte growth factor (HGF), eliciting its diverse biological activities that...
Na minha lista:
| Publicado no: | World J Biol Chem |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436902/ https://ncbi.nlm.nih.gov/pubmed/26009700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4331/wjbc.v6.i2.16 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|